145 related articles for article (PubMed ID: 17704324)
1. Rho/ROCK pathway as a molecular target for modulation of intestinal radiation-induced toxicity.
Haydont V; Bourgier C; Vozenin-Brotons MC
Br J Radiol; 2007 Sep; 80 Spec No 1():S32-40. PubMed ID: 17704324
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Rho kinase modulates radiation induced fibrogenic phenotype in intestinal smooth muscle cells through alteration of the cytoskeleton and connective tissue growth factor expression.
Bourgier C; Haydont V; Milliat F; François A; Holler V; Lasser P; Bourhis J; Mathé D; Vozenin-Brotons MC
Gut; 2005 Mar; 54(3):336-43. PubMed ID: 15710979
[TBL] [Abstract][Full Text] [Related]
3. Pravastatin Inhibits the Rho/CCN2/extracellular matrix cascade in human fibrosis explants and improves radiation-induced intestinal fibrosis in rats.
Haydont V; Bourgier C; Pocard M; Lusinchi A; Aigueperse J; Mathé D; Bourhis J; Vozenin-Brotons MC
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5331-40. PubMed ID: 17875761
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the Rho/ROCK pathway in heart and lung after thorax irradiation reveals targets to improve normal tissue toxicity.
Monceau V; Pasinetti N; Schupp C; Pouzoulet F; Opolon P; Vozenin MC
Curr Drug Targets; 2010 Nov; 11(11):1395-404. PubMed ID: 20583978
[TBL] [Abstract][Full Text] [Related]
5. The Rho-ROCK system as a new therapeutic target for preventing interstitial fibrosis.
Moriyama T; Nagatoya K
Drug News Perspect; 2004; 17(1):29-34. PubMed ID: 14993932
[TBL] [Abstract][Full Text] [Related]
6. Molecular aspects of chronic radiation enteritis.
Zhu Y; Zhou J; Tao G
Clin Invest Med; 2011 Jun; 34(3):E119-24. PubMed ID: 21631987
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta2 and connective tissue growth factor in proliferative vitreoretinal diseases: possible involvement of hyalocytes and therapeutic potential of Rho kinase inhibitor.
Kita T; Hata Y; Kano K; Miura M; Nakao S; Noda Y; Shimokawa H; Ishibashi T
Diabetes; 2007 Jan; 56(1):231-8. PubMed ID: 17192487
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacological modulation of late radio-induced side effects].
Bourgier C; Monceau V; Bourhis J; Deutsch E; Vozenin MC
Cancer Radiother; 2011 Aug; 15(5):383-9. PubMed ID: 21596606
[TBL] [Abstract][Full Text] [Related]
9. [Role of the Rho/Rho-kinase pathway in the development of hypertensive glomerulosclerosis: renoprotective effect of Rho-kinase inhibitor in hypertensive glomerulosclerosis and its molecular mechanism].
Nishikimi T
Nihon Yakurigaku Zasshi; 2006 Sep; 128(3):153-9, 152. PubMed ID: 16971778
[No Abstract] [Full Text] [Related]
10. Molecular aspects of intestinal radiation-induced fibrosis.
Gervaz P; Morel P; Vozenin-Brotons MC
Curr Mol Med; 2009 Apr; 9(3):273-80. PubMed ID: 19355909
[TBL] [Abstract][Full Text] [Related]
11. Rho kinase: a target for treating urinary bladder dysfunction?
Peters SL; Schmidt M; Michel MC
Trends Pharmacol Sci; 2006 Sep; 27(9):492-7. PubMed ID: 16870270
[TBL] [Abstract][Full Text] [Related]
12. Progress of the study of rho-kinase and future perspective of the inhibitor.
Tawara S; Shimokawa H
Yakugaku Zasshi; 2007 Mar; 127(3):501-14. PubMed ID: 17329936
[TBL] [Abstract][Full Text] [Related]
13. RhoA/Rho-associated kinase pathway selectively regulates thrombin-induced intercellular adhesion molecule-1 expression in endothelial cells via activation of I kappa B kinase beta and phosphorylation of RelA/p65.
Anwar KN; Fazal F; Malik AB; Rahman A
J Immunol; 2004 Dec; 173(11):6965-72. PubMed ID: 15557193
[TBL] [Abstract][Full Text] [Related]
14. Radiation fibrosis--current clinical and therapeutic perspectives.
Westbury CB; Yarnold JR
Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):657-72. PubMed ID: 22608361
[TBL] [Abstract][Full Text] [Related]
15. ROCKs as therapeutic targets in cardiovascular diseases.
Rikitake Y; Liao JK
Expert Rev Cardiovasc Ther; 2005 May; 3(3):441-51. PubMed ID: 15889972
[TBL] [Abstract][Full Text] [Related]
16. Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction.
Nagatoya K; Moriyama T; Kawada N; Takeji M; Oseto S; Murozono T; Ando A; Imai E; Hori M
Kidney Int; 2002 May; 61(5):1684-95. PubMed ID: 11967018
[TBL] [Abstract][Full Text] [Related]
17. The role of the RhoA/Rho-kinase signaling pathway in renal vascular reactivity in endothelial nitric oxide synthase null mice.
Williams J; Bogwu J; Oyekan A
J Hypertens; 2006 Jul; 24(7):1429-36. PubMed ID: 16794494
[TBL] [Abstract][Full Text] [Related]
18. Rho kinase in the regulation of cell death and survival.
Shi J; Wei L
Arch Immunol Ther Exp (Warsz); 2007; 55(2):61-75. PubMed ID: 17347801
[TBL] [Abstract][Full Text] [Related]
19. Rho kinase-induced nuclear translocation of ERK1/ERK2 in smooth muscle cell mitogenesis caused by serotonin.
Liu Y; Suzuki YJ; Day RM; Fanburg BL
Circ Res; 2004 Sep; 95(6):579-86. PubMed ID: 15297378
[TBL] [Abstract][Full Text] [Related]
20. Current management for late normal tissue injury: radiation-induced fibrosis and necrosis.
Delanian S; Lefaix JL
Semin Radiat Oncol; 2007 Apr; 17(2):99-107. PubMed ID: 17395040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
